Related Experiment Video
Updated: Feb 10, 2026

Identifying Coronary Artery Calcification on Non-gated Computed Tomography Scans
Published on: August 28, 2018
Prognostic Value of MicroRNAs in Coronary Artery Diseases: A Meta-Analysis
Ji Suk Kim1,2, Kyoungjune Pak1,3, Tae Sik Goh1,4
1BEER, Busan Society of Evidence-based Mdicine and Research, Busan, Korea.
Purpose:
Coronary artery diseases (CADs) are the leading causes of death in the world. Recent studies have reported that differentially expressed microRNAs (miRNAs) are associated with prognosis or major adverse cardiac events (MACEs) in CAD patients. In a previous meta-analysis, the authors made serious mistakes that we aimed to correct through an updated systematic review and meta-analysis of the prognostic value of altered miRNAs in patients with CADs.
Materials And Methods:
We performed a systematic search of MEDLINE (from inception to May 2017) and EMBASE (from inception to May 2017) for English-language publications. Studies of CADs with results on miRNAs that reported survival data or MACEs were included. Data were extracted from each publication independently by two reviewers.
Results:
After reviewing 515 articles, a total eight studies were included in this study. We measured pooled hazard ratios (HRs) and 95% confidence intervals (CIs) of miRNA 133a with a fixed-effect model (pooled HR, 2.35; 95% CI, 1.56-3.55). High expression of miRNA 133a, 208b, 126, 197, 223, and 122-5p were associated with high mortality. Additionally, high levels of miRNA 208b, 499-5p, 134, 328, and 34a were related with MACEs.
Conclusion:
The present study confirmed that miRNA 133a, which was associated with high mortality in CAD patients, holds prognostic value in CAD. More importantly, this study corrected issues raised against a prior meta-analysis and provides accurate information.
Insights
This study confirms microRNA 133a has prognostic value in coronary artery disease (CAD) patients, associating its high expression with increased mortality. It corrects errors in a previous meta-analysis, providing accurate miRNA prognostic data for CAD.
Area of Science:
- Biomedical research
- Cardiovascular medicine
- Molecular biology
Background:
- Coronary artery diseases (CADs) are a leading global cause of mortality.
- MicroRNAs (miRNAs) are increasingly recognized as potential biomarkers for cardiovascular prognosis.
- Previous meta-analyses on miRNA prognostic value in CAD have contained significant errors.
Purpose of the Study:
- To conduct an updated systematic review and meta-analysis of the prognostic value of altered miRNAs in patients with CAD.
- To correct inaccuracies identified in a prior meta-analysis concerning miRNA and CAD prognosis.
- To provide reliable data on the association between specific miRNAs and clinical outcomes in CAD.
Main Methods:
- Systematic literature search of MEDLINE and EMBASE databases up to May 2017.
- Inclusion of studies reporting survival data or major adverse cardiac events (MACEs) in CAD patients with miRNA analysis.
- Independent data extraction by two reviewers and pooled hazard ratio (HR) calculation using a fixed-effect model.
Main Results:
- Eight studies were included after reviewing 515 articles.
- High expression of miRNA 133a was significantly associated with increased mortality (pooled HR, 2.35; 95% CI, 1.56-3.55).
- Elevated levels of several other miRNAs (e.g., 208b, 126, 197) were linked to higher mortality, while others (e.g., 208b, 499-5p, 134) were associated with MACEs.
Conclusions:
- MicroRNA 133a demonstrates significant prognostic value in coronary artery disease patients, particularly regarding mortality.
- This updated meta-analysis provides corrected and accurate information on miRNA prognostic implications in CAD.
- The findings underscore the potential of specific miRNAs as biomarkers for risk stratification in CAD.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
MicroRNAs